Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Sphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit
, /in Product News /by panglobalSphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, have launched a biocompatible CYTRIX Microfluidic Hydrogel Kit.
Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards
, /in E-News /by panglobalThe Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at the OBN 2020 Awards. The award recognises the company’s outstanding contribution to the fight against COVID-19.
BioChromato develops optimized tube plate for enzyme studies
, /in Product News /by panglobalBioChromato has developed an enzyme assay product – the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies.
Transgene strengthen global IP protection for its novel Invir.IO oncolytic viruses encoding ICIs
, /in E-News /by panglobalTransgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, has received a patent from the Japan Patent Office for their oncolytic virus (OV) backbone VVcopTK-RR- that encodes one or more immune checkpoint inhibitors (ICIs).
Lunaphore appoints Matthias Weber, former President of Leica Biosystems, to Board of Directors
, /in E-News /by panglobalLunaphore Technologies, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, has appointed Matthias Weber, former President of Leica Biosystems, to its Board of Directors. Weber has been appointed to represent the interests of strategic investor PHC Holdings Corporation (PHCHD), who previously invested in Lunaphore through a Series C financing round in 2020.
Bio-Rad launches SEQuoia RiboDepletion Kit for next-gen sequencing
, /in Product News /by Bio-Rad LaboratoriesBio-Rad Laboratories recently launched the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.
Iksuda Therapeutics closes $47 million financing round
, /in E-News /by panglobalIksuda Therapeutics, the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, has completed a US$47 million financing round, co-led by Mirae Asset Capital and its subsidiaries, Celltrion and Premier Partners. The funding will support the advancement of Iksuda’s lead ADC assets and expansion of its payload and conjugation platform […]
Aptamer Group, PinotBio collaborate to develop Optimer-drug conjugates
, /in E-News /by panglobalAptamer Group, the developer of Optimer Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, have entered into a strategic collaboration agreement. The agreement is to develop Optimer-drug conjugates for targeted drug delivery combining Aptamer Group’s Optimer technology with PinotBio’s technology using the chemotherapeutic FL-118 compound with specific linker.
Beyondis reports positive results from Phase III trial of antibody-drug conjugate for breast cancer
, /in E-News /by panglobalByondis has reported positive topline results from the Phase III TULIP study, a multi-centre, open-label, randomized clinical trial. The trial compared the efficacy and safety of the company’s antibody-drug conjugate (ADC) [vic-]trastuzumab duocarmazine (SYD985) to physician’s choice treatment in patients with pretreated HER2-positive unresectable locally advanced or metastatic breast cancer.
Study shows Nova POC Creatinine/eGFR method more accurate PRODUCT than laboratory method
, /in Product News /by panglobalIn a 670-patient study funded by the International Society of Nephrology, the South Africa Medical Research Council, and the University of Witwatersrand, Johannesburg, South Africa, the Nova POC StatSensor Creatinine/eGFR meter was more accurate than the central laboratory IDMS-traceable Jaffe methodology in estimating GFR when both methods were compared to measured GFR (mGFR).